These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15907915)

  • 1. Botulinal neurotoxins: revival of an old killer.
    Montecucco C; Molgó J
    Curr Opin Pharmacol; 2005 Jun; 5(3):274-9. PubMed ID: 15907915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic enzymatic neurotoxins.
    Rossetto O; Morbiato L; Caccin P; Rigoni M; Montecucco C
    J Neurochem; 2006 Jun; 97(6):1534-45. PubMed ID: 16805767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the mechanism of action of tetanus and botulinum neurotoxins.
    Rossetto O; Pirazzini M; Bolognese P; Rigoni M; Montecucco C
    Acta Chim Slov; 2011 Dec; 58(4):702-7. PubMed ID: 24061118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Neurotoxins: Mechanism of Action.
    Rossetto O; Pirazzini M; Fabris F; Montecucco C
    Handb Exp Pharmacol; 2021; 263():35-47. PubMed ID: 32277300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus and botulinum neurotoxins: turning bad guys into good by research.
    Rossetto O; Seveso M; Caccin P; Schiavo G; Montecucco C
    Toxicon; 2001 Jan; 39(1):27-41. PubMed ID: 10936621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in searching for therapeutics against Botulinum Neurotoxins.
    Pirazzini M; Rossetto O
    Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal selectivity of botulinum neurotoxins.
    Poulain B; Lemichez E; Popoff MR
    Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxins 99, new information about the botulinum neurotoxins.
    Carruthers A; Carruthers J
    Dermatol Surg; 2000 Mar; 26(3):174-6. PubMed ID: 10759788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].
    Poulain B; Humeau Y
    Ann Readapt Med Phys; 2003 Jul; 46(6):265-75. PubMed ID: 12928128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
    Turton K; Chaddock JA; Acharya KR
    Trends Biochem Sci; 2002 Nov; 27(11):552-8. PubMed ID: 12417130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of intestinal absorption of botulinum neurotoxin complex].
    Matsumura T
    Nihon Saikingaku Zasshi; 2019; 74(3):167-175. PubMed ID: 31787706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxins: genetic, structural and mechanistic insights.
    Rossetto O; Pirazzini M; Montecucco C
    Nat Rev Microbiol; 2014 Aug; 12(8):535-49. PubMed ID: 24975322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxins: mechanism of action and therapeutic applications.
    Montecucco C; Schiavo G; Tugnoli V; de Grandis D
    Mol Med Today; 1996 Oct; 2(10):418-24. PubMed ID: 8897436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.
    Pellizzari R; Rossetto O; Schiavo G; Montecucco C
    Philos Trans R Soc Lond B Biol Sci; 1999 Feb; 354(1381):259-68. PubMed ID: 10212474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future aspects of botulinum neurotoxins.
    Aoki KR
    J Neural Transm (Vienna); 2008; 115(4):567-73. PubMed ID: 17557128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of botulinum neurotoxin type A for cosmetic applications.
    Carruthers J; Carruthers A
    J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.